Radial flow effects on a retreating rotor blade

This work studies the effects of radial flow on the aerodynamic phenomena occurring on a retreating blade with a focus on dynamic stall and reverse flow as applied to both a helicopter rotor in forward flight and a wind turbine operating at a yaw angle. While great progress has been made in understanding the phenomenon of two-dimensional dynamic stall, the effect of rotation on the dynamic stall event is not well understood. Experiments were conducted on a rigid two bladed teetering rotor at high advance ratios in a low speed wind tunnel. Particle image velocimetry (PIV) measurements were used to quantify the flow field at several azimuthal angles on the rotating blade during the dynamic stall event. The effect of centrifugal forces induced ``pure'' radial velocity on the dynamic stall event at 270 degrees azimuth was studied in detail. Further investigation of the radial flow field suggested that the mean radial velocity attenuated on moving outboard due to an apparent shear layer instability and it was demonstrated to be of first order importance in the flow field. These radial flow results prompted an exploration of the flow over a rotating disk to establish similarities of the radial flow over rotating blade in separated flow to that over a rotating disk in separated flow. While a greater part of this work focused on aspects of dynamic stall on the retreating blade, the final parts focus on the exotic flow regime of reverse flow (characterized by flow from the trailing edge to the leading edge of the blade). Aerodynamic loads measurement and surface flow visualization via tufts are used to first quantify the behavior of a static yawed blade in reverse flow. PIV measurements are then used on a static yawed blade and a rotating blade in reverse flow conditions to ascertain the effects of rotation on reverse flow.Ph.D

Diagnostics of flow separation on rotor blades

Issued as final reportUnited States. Army Research Offic

On the Mechanics of Transcatheter Aortic Valve Replacement.

Transcatheter aortic valves (TAVs) represent the latest advances in prosthetic heart valve technology. TAVs are truly transformational as they bring the benefit of heart valve replacement to patients that would otherwise not be operated on. Nevertheless, like any new device technology, the high expectations are dampened with growing concerns arising from frequent complications that develop in patients, indicating that the technology is far from being mature. Some of the most common complications that plague current TAV devices include malpositioning, crimp-induced leaflet damage, paravalvular leak, thrombosis, conduction abnormalities and prosthesis-patient mismatch. In this article, we provide an in-depth review of the current state-of-the-art pertaining the mechanics of TAVs while highlighting various studies guiding clinicians, regulatory agencies, and next-generation device designers

The Peak Index: Spirometry Metric for Airflow Obstruction Severity and Heterogeneity

Rationale: Chronic obstructive pulmonary disease (COPD) is characterized by airflow limitation. Spirometry loops are not smooth curves and have undulations and peaks that likely reflect heterogeneity of airflow.Objectives: To assess whether the Peak Index, the number of peaks adjusted for lung size, is associated with clinical outcomes.Methods: We analyzed spirometry data of 9,584 participants enrolled in the COPDGene study and counted the number of peaks in the descending part of the expiratory flow-volume curve from the peak expiratory flow to end-expiration. We adjusted the peaks count for the volume of the lungs from peak expiratory flow to end-expiration to derive the Peak Index. Multivariable regression analyses were performed to test associations between the Peak Index and lung function, respiratory morbidity, structural lung disease on computed tomography (CT), forced expiratory volume in 1 second (FEV1) decline, and mortality.Results: The Peak Index progressively increased from Global Initiative for Chronic Obstructive Lung Disease stage 0 through 4 (P < 0.001). On multivariable analysis, the Peak Index was significantly associated with CT emphysema (adjusted β = 0.906; 95% confidence interval [CI], 0.789 to 1.023; P < 0.001) and small airways disease (adjusted β = 1.367; 95% CI, 1.188 to 1.545; P < 0.001), St. George's Respiratory Questionnaire score (adjusted β = 1.075; 95% CI, 0.807 to 1.342; P < 0.001), 6-minute-walk distance (adjusted β = -1.993; 95% CI, -3.481 to -0.506; P < 0.001), and FEV1 change over time (adjusted β = -1.604; 95% CI, -2.691 to -0.516; P = 0.004), after adjustment for age, sex, race, body mass index, current smoking status, pack-years of smoking, and FEV1. The Peak Index was also associated with the BODE (body mass index, airflow obstruction, dyspnea, and exercise capacity) index and mortality (P < 0.001).Conclusions: The Peak Index is a spirometry metric that is associated with CT measures of lung disease, respiratory morbidity, lung function decline, and mortality.Clinical trial registered with www.clinicaltrials.gov (NCT00608764)